BioatlaInc Cost Of Revenue vs Reconciled Depreciation Analysis

BCAB Stock

USD 2.54 0.29 12.89%

BioatlaInc financial indicator trend analysis is way more than just evaluating BioatlaInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioatlaInc is a good investment. Please check the relationship between BioatlaInc Cost Of Revenue and its Reconciled Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioatlaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioatlaInc Cost Of Revenue account and Reconciled Depreciation. At this time, the significance of the direction appears to have almost identical trend.

The correlation between BioatlaInc's Cost Of Revenue and Reconciled Depreciation is 0.94. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of BioatlaInc, assuming nothing else is changed. The correlation between historical values of BioatlaInc's Cost Of Revenue and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of BioatlaInc are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Cost Of Revenue i.e., BioatlaInc's Cost Of Revenue and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on BioatlaInc income statement and represents the costs associated with goods and services BioatlaInc provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Reconciled Depreciation

Most indicators from BioatlaInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioatlaInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioatlaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 145.21, whereas Selling General Administrative is forecasted to decline to about 24.7 K.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.7M	1.7M	1.2M	1.4M
Interest Income	350K	1.6M	5.7M	6.0M

Depreciation And Amortization Interest Income

BioatlaInc fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.91	0.71	0.74	1.0	-0.62	0.94	0.64	0.91	-1.0	-0.47	0.18	1.0	0.66	0.81	-0.16	-0.91	1.0	-0.94	0.72	-0.88	0.29	0.89	-0.43	1.0	0.78
Short Long Term Debt Total	-0.91		-0.79	-0.78	-0.91	0.72	-0.99	-0.36	-0.97	0.9	0.68	-0.26	-0.91	-0.38	-0.79	0.42	0.92	-0.91	0.98	-0.82	0.94	-0.59	-0.93	0.51	-0.93	-0.73
Other Current Liab	0.71	-0.79		0.74	0.69	-0.18	0.85	0.39	0.88	-0.7	-0.88	0.51	0.71	0.41	0.83	-0.54	-0.88	0.71	-0.86	0.95	-0.59	0.71	0.93	0.02	0.74	0.92
Total Current Liabilities	0.74	-0.78	0.74		0.71	-0.44	0.8	0.31	0.83	-0.73	-0.59	0.68	0.74	0.34	0.96	-0.17	-0.91	0.74	-0.82	0.9	-0.8	0.5	0.77	0.04	0.74	0.57
Total Stockholder Equity	1.0	-0.91	0.69	0.71		-0.65	0.93	0.62	0.9	-1.0	-0.44	0.13	1.0	0.64	0.77	-0.15	-0.89	1.0	-0.94	0.69	-0.89	0.26	0.88	-0.48	1.0	0.75
Other Liab	-0.62	0.72	-0.18	-0.44	-0.65		-0.62	0.02	-0.56	0.63	0.11	0.18	-0.63	0.01	-0.31	0.05	0.47	-0.63	0.59	-0.27	0.87	-0.2	-0.45	0.81	-0.64	-0.09
Net Tangible Assets	0.94	-0.99	0.85	0.8	0.93	-0.62		0.48	0.99	-0.93	-0.71	0.28	0.94	0.5	0.85	-0.39	-0.96	0.94	-1.0	0.86	-0.9	0.59	0.96	-0.42	0.95	0.82
Property Plant And Equipment Net	0.64	-0.36	0.39	0.31	0.62	0.02	0.48		0.47	-0.62	-0.18	0.01	0.64	1.0	0.54	0.17	-0.53	0.64	-0.5	0.33	-0.27	-0.02	0.45	-0.05	0.59	0.67
Current Deferred Revenue	0.91	-0.97	0.88	0.83	0.9	-0.56	0.99	0.47		-0.89	-0.77	0.38	0.91	0.49	0.88	-0.44	-0.97	0.91	-0.99	0.9	-0.87	0.65	0.96	-0.35	0.92	0.83
Net Debt	-1.0	0.9	-0.7	-0.73	-1.0	0.63	-0.93	-0.62	-0.89		0.43	-0.16	-1.0	-0.63	-0.79	0.13	0.9	-1.0	0.93	-0.71	0.88	-0.25	-0.89	0.42	-1.0	-0.76
Retained Earnings	-0.47	0.68	-0.88	-0.59	-0.44	0.11	-0.71	-0.18	-0.77	0.43		-0.57	-0.46	-0.19	-0.67	0.81	0.71	-0.46	0.71	-0.84	0.44	-0.91	-0.76	0.03	-0.5	-0.76
Accounts Payable	0.18	-0.26	0.51	0.68	0.13	0.18	0.28	0.01	0.38	-0.16	-0.57		0.18	0.03	0.65	-0.39	-0.5	0.18	-0.33	0.67	-0.21	0.41	0.38	0.55	0.18	0.33
Cash	1.0	-0.91	0.71	0.74	1.0	-0.63	0.94	0.64	0.91	-1.0	-0.46	0.18		0.66	0.81	-0.15	-0.91	1.0	-0.94	0.72	-0.88	0.28	0.89	-0.43	1.0	0.77
Non Current Assets Total	0.66	-0.38	0.41	0.34	0.64	0.01	0.5	1.0	0.49	-0.63	-0.19	0.03	0.66		0.56	0.16	-0.55	0.66	-0.51	0.35	-0.28	-0.01	0.47	-0.05	0.61	0.68
Non Currrent Assets Other	0.81	-0.79	0.83	0.96	0.77	-0.31	0.85	0.54	0.88	-0.79	-0.67	0.65	0.81	0.56		-0.22	-0.96	0.81	-0.87	0.93	-0.74	0.51	0.84	0.06	0.8	0.76
Other Assets	-0.16	0.42	-0.54	-0.17	-0.15	0.05	-0.39	0.17	-0.44	0.13	0.81	-0.39	-0.15	0.16	-0.22		0.31	-0.15	0.39	-0.47	0.18	-0.73	-0.47	0.18	-0.19	-0.45
Long Term Debt	-0.91	0.92	-0.88	-0.91	-0.89	0.47	-0.96	-0.53	-0.97	0.9	0.71	-0.5	-0.91	-0.55	-0.96	0.31		-0.91	0.97	-0.93	0.85	-0.56	-0.94	0.17	-0.92	-0.82
Cash And Short Term Investments	1.0	-0.91	0.71	0.74	1.0	-0.63	0.94	0.64	0.91	-1.0	-0.46	0.18	1.0	0.66	0.81	-0.15	-0.91		-0.94	0.72	-0.88	0.28	0.89	-0.43	1.0	0.77
Common Stock Total Equity	-0.94	0.98	-0.86	-0.82	-0.94	0.59	-1.0	-0.5	-0.99	0.93	0.71	-0.33	-0.94	-0.51	-0.87	0.39	0.97	-0.94		-0.88	0.89	-0.57	-0.97	0.38	-0.96	-0.83
Common Stock Shares Outstanding	0.72	-0.82	0.95	0.9	0.69	-0.27	0.86	0.33	0.9	-0.71	-0.84	0.67	0.72	0.35	0.93	-0.47	-0.93	0.72	-0.88		-0.69	0.7	0.9	0.06	0.74	0.81
Non Current Liabilities Total	-0.88	0.94	-0.59	-0.8	-0.89	0.87	-0.9	-0.27	-0.87	0.88	0.44	-0.21	-0.88	-0.28	-0.74	0.18	0.85	-0.88	0.89	-0.69		-0.4	-0.79	0.55	-0.89	-0.49
Other Current Assets	0.29	-0.59	0.71	0.5	0.26	-0.2	0.59	-0.02	0.65	-0.25	-0.91	0.41	0.28	-0.01	0.51	-0.73	-0.56	0.28	-0.57	0.7	-0.4		0.57	-0.14	0.32	0.5
Other Stockholder Equity	0.89	-0.93	0.93	0.77	0.88	-0.45	0.96	0.45	0.96	-0.89	-0.76	0.38	0.89	0.47	0.84	-0.47	-0.94	0.89	-0.97	0.9	-0.79	0.57		-0.25	0.92	0.9
Total Liab	-0.43	0.51	0.02	0.04	-0.48	0.81	-0.42	-0.05	-0.35	0.42	0.03	0.55	-0.43	-0.05	0.06	0.18	0.17	-0.43	0.38	0.06	0.55	-0.14	-0.25		-0.44	-0.05
Net Invested Capital	1.0	-0.93	0.74	0.74	1.0	-0.64	0.95	0.59	0.92	-1.0	-0.5	0.18	1.0	0.61	0.8	-0.19	-0.92	1.0	-0.96	0.74	-0.89	0.32	0.92	-0.44		0.78
Property Plant And Equipment Gross	0.78	-0.73	0.92	0.57	0.75	-0.09	0.82	0.67	0.83	-0.76	-0.76	0.33	0.77	0.68	0.76	-0.45	-0.82	0.77	-0.83	0.81	-0.49	0.5	0.9	-0.05	0.78

Click cells to compare fundamentals

BioatlaInc Account Relationship Matchups

BioatlaInc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.3M	244.9M	254.4M	225.7M	119.7M	159.6M
Short Long Term Debt Total	18.1M	682K	5.4M	4.0M	2.5M	2.3M
Other Current Liab	10.5M	10.0M	17.2M	17.4M	22.9M	15.6M
Total Current Liabilities	26.7M	32.3M	19.8M	23.1M	28.3M	25.6M
Total Stockholder Equity	(56.0M)	210.0M	210.8M	180.3M	70.7M	107.7M
Net Tangible Assets	(145.3M)	210.0M	210.8M	180.3M	207.4M	217.8M
Property Plant And Equipment Net	4.7M	4.1M	7.0M	5.2M	3.1M	5.1M
Net Debt	14.4M	(237.9M)	(239.6M)	(211.5M)	(109.0M)	(114.5M)
Retained Earnings	(148.4M)	(90.9M)	(186.3M)	(292.8M)	(416.3M)	(395.4M)
Accounts Payable	5.1M	2.5M	1.2M	4.2M	3.8M	3.4M
Cash	3.7M	238.6M	245.0M	215.5M	111.5M	151.3M
Non Current Assets Total	4.8M	4.3M	7.1M	5.3M	3.3M	5.3M
Cash And Short Term Investments	3.7M	238.6M	245.0M	215.5M	111.5M	151.3M
Liabilities And Stockholders Equity	9.3M	244.9M	254.4M	225.7M	119.7M	159.6M
Non Current Liabilities Total	38.6M	2.7M	23.8M	22.3M	20.6M	19.2M
Other Current Assets	214K	72K	502K	539K	4.9M	5.2M
Other Stockholder Equity	2.3M	300.9M	397.1M	473.1M	486.9M	304.7M
Total Liab	65.3M	35.0M	43.6M	45.4M	49.0M	37.8M
Net Invested Capital	(127.2M)	210.7M	210.8M	180.3M	70.7M	81.1M
Property Plant And Equipment Gross	4.7M	4.1M	11.2M	10.5M	9.2M	8.0M
Total Current Assets	4.5M	240.7M	247.3M	220.4M	116.4M	154.4M
Net Working Capital	(22.2M)	208.4M	227.5M	197.3M	88.1M	128.8M
Property Plant Equipment	4.7M	4.1M	7.0M	2.7M	3.1M	4.9M

Pair Trading with BioatlaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioatlaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioatlaInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with BioatlaInc Stock

0.67

ELEV

Elevation Oncology Earnings Call This Week

Pair Corr

The ability to find closely correlated positions to BioatlaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioatlaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioatlaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioatlaInc to buy it.

The correlation of BioatlaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioatlaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioatlaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for BioatlaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether BioatlaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioatlaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatlainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatlainc Stock:

How To Invest In BioatlaInc

Details

Is BioatlaInc Stock a good investment?

Details

What is BioatlaInc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioatlaInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade BioatlaInc Stock refer to our How to Trade BioatlaInc Stock guide.

Note that the BioatlaInc information on this page should be used as a complementary analysis to other BioatlaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for BioatlaInc Stock analysis

When running BioatlaInc's price analysis, check to measure BioatlaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioatlaInc is operating at the current time. Most of BioatlaInc's value examination focuses on studying past and present price action to predict the probability of BioatlaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioatlaInc's price. Additionally, you may evaluate how the addition of BioatlaInc to your portfolios can decrease your overall portfolio volatility.

	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope

Is BioatlaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioatlaInc. If investors know BioatlaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioatlaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.58)

Quarterly Revenue Growth

0.316

Return On Assets

(0.47)

Return On Equity

(0.98)

The market value of BioatlaInc is measured differently than its book value, which is the value of BioatlaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BioatlaInc's value that differs from its market value or its book value, called intrinsic value, which is BioatlaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioatlaInc's market value can be influenced by many factors that don't directly affect BioatlaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BioatlaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioatlaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioatlaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioatlaInc Cost Of Revenue vs Reconciled Depreciation Analysis

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Reconciled Depreciation

BioatlaInc fundamental ratios Correlations

BioatlaInc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioatlaInc fundamental ratios Accounts

Pair Trading with BioatlaInc

Moving together with BioatlaInc Stock

Complementary Tools for BioatlaInc Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity

Net Invested Capital	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Common Stock Total Equity	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Total Stockholder Equity
Net Debt	- 1.0	Total Assets